IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kaken Pharmaceutical Co LTD

CUSIP: 6481643 | 3 institutional holders

Quarters

Q3 2016Q2 2015Q1 2015Q4 2014
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Copeland Capital Management, LLC6,561
0.0% of portfolio›$400
StyleTurnoverLocationFiled
Copeland Capital Management, LLC
6,561$4000.0%ValueMediumConshohocken, PA2016-11-02